Our goal is to ensure the next generation grows up safe from deadly infectious diseases. We work with partners to develop safe and effective vaccines that protect against preventable diseases and to expand access to these vaccines for people in lower-income countries.
On Friday, April 17, Mark Suzman, CEO of the Gates Foundation, joined a conference call with The Optimist subscribers to discuss the foundation’s response to the COVID-19 pandemic. Listen to…
SEATTLE, April 15, 2020 – The Bill & Melinda Gates Foundation today announced an expansion of its funding for the global response to COVID-19. The increase includes an additional $150…
CEO Mark Suzman reflects on the foundation’s unique position to respond to the COVID-19 crisis and shares an update on the foundation’s more than $250 million commitment to funding response…
Oumar Seydi, Africa director for the Bill & Melinda Gates Foundation, shares the foundation’s two-pronged response to coronavirus in Africa: short-term assistance to bolster the immediate response, and long-term support…
Trevor Mundel, who leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries, discusses the first trials funded through the Therapeutics…
Dr. Erin Stuckey of the foundation’s polio eradication team shares details on the team’s pivot to COVID-19. They underscore the importance of using the response to strengthen health systems—because when…
Bill & Melinda Gates Foundation CEO Mark Suzman shares measures the public can take to help curb COVID-19 from home. By collectively following public health guidance, practicing physical distancing, and…
Allan Golston, president of U.S. Programs at the Bill & Melinda Gates Foundation, delves into the foundation’s strategy for education during and after COVID-19 to ensure successful and equitable online…
Amy Carter, director of Community Engagement, discusses the two-pronged approach the foundation is taking to tackle COVID-19 in Seattle: deploying money and expertise.
SEATTLE, March 25, 2020 – Today, a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture, and delivery of vaccines, diagnostics, and treatments for COVID-19.…
